Du diagnostic à la prise en soins des principales céphalées primaires indiquées à la rééducation : migraine et céphalée de tension
Authors:
- Diana DoukhiDDDiana Doukhi
- Anthony DemontADAnthony Demont
- Jérôme MawetJMJérôme Mawet
- 8 November 2025
- journal article
- Published by Elsevier in Kinésithérapie, la Revue
- Vol. 25 (288) , 17-23
Abstract
No abstract availableThis publication has 35 references indexed in Scilit:
- Migraine treatment: Position paper of the French Headache SocietyRevue Neurologique, 2024
- Atogepant for the preventive treatment of chronic migraine (PROGRESS): a randomised, double-blind, placebo-controlled, phase 3 trialThe Lancet, 2023
- Revised guidelines of the French headache society for the diagnosis and management of migraine in adults. Part 3: Non-pharmacological treatmentRevue Neurologique, 2021
- Revised guidelines of the French headache society for the diagnosis and management of migraine in adults. Part 2: Pharmacological treatmentRevue Neurologique, 2021
- Heartrate variability biofeedback for migraine using a smartphone application and sensor: A randomized controlled trialGeneral Hospital Psychiatry, 2021
- Oral rimegepant for preventive treatment of migraine: a phase 2/3, randomised, double-blind, placebo-controlled trialThe Lancet, 2021
- Global, regional, and national burden of migraine and tension-type headache, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016The Lancet Neurology, 2018
- The pathophysiology of migraine: implications for clinical managementThe Lancet Neurology, 2018
- Epidemiology of migraine: French key descriptive dataRevue Neurologique, 2016
- Tension-type headache: current research and clinical managementThe Lancet Neurology, 2008